Literature DB >> 1225337

Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery.

D J Coltart, M N Cayen, E B Stinson, R H Goldman, R O Davies, D C Harrison.   

Abstract

The time necessary for dissipation of radioactive labelled propranolol and its metabolites and the cardiac effects of this agent in the hearts of patients undergoing open-heart surgery were studied. Isoprenaline produced chronotropic and inotropic responses in atrial muscle in tissue bath studies which were normal 8 to 12 hours after withdrawing propranolol. After the administration of either 25 or 75 muCi of 14C-labelled propranolol, the myocardial tissue concentration declined to insignificant levels between 24 and 28 hours. We conclude that withdrawal of propranolol therapy 24 to 48 hours before cardiac surgery should be acceptable.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1225337      PMCID: PMC482945          DOI: 10.1136/hrt.37.12.1228

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

1.  Time required for complete recovery from chronic propranolol therapy.

Authors:  S L Faulkner; J T Hopkins; R C Boerth; J L Young; L V Jellett; A S Nies; H W Bender; D G Shand
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

2.  Withdrawal of propranolol and myocardial infarction.

Authors:  R Slome
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

3.  The disposition of propranolol. I. Elimination during oral absorption in man.

Authors:  D G Shand; R E Rangno
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

4.  Propranolol and cardiac surgery.

Authors:  J F Viljoen; F G Estafanous; G A Kellner
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

5.  Development of human foetal inotropic responses to catecholamines.

Authors:  D J Coltart; B A Spilker
Journal:  Experientia       Date:  1972-05-15

6.  Systolic time intervals in heart failure in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Circulation       Date:  1968-02       Impact factor: 29.690

7.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

8.  Coronary artery syndromes after sudden propranolol withdrawal.

Authors:  E L Alderman; D J Coltart; G E Wettach; D C Harrison
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

9.  Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.

Authors:  A Hayes; R G Cooper
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

10.  Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.

Authors:  J D Fitzgerald; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

View more
  3 in total

1.  Adaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits.

Authors:  A E Raine; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

2.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

3.  Predictors of operative mortality for coronary bypass grafting in patients with ischemic heart disease.

Authors:  R A Langou; J C Wiles; P N Peduzzi; G Hammond; L S Cohen
Journal:  Yale J Biol Med       Date:  1978 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.